In A549 and primary human NSCLC cells, GDC-0349 inhibits NSCLC cell growth, proliferation, cell cycle progression, migration, and invasion through the Akt-Akt-mTOR pathway, while inducing significant apoptotic activation (Yang et al., 2020). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.